AMGN
NASDAQ
$364.17
AMGEN Inc (AMGN)
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Buy
Target: $356.62 (-2.07%)
Market Cap
$193B
PEG Ratio
0.79
Profit Margin
21.1%
Forward P/E
16.47
Price Chart
Valuation
Market Cap$193B
P/E24.75
Forward P/E16.47
PEG0.79
P/S5.15
P/B21.17
Profitability
Total Revenue (TTM)$37B
Gross Profit (TTM)$27B
EBITDA$15B
Profit Margin21.1%
Operating Margin30.9%
EPS$14.48
Financial Health
Debt-to-Equity623.8%
Free Cash Flow Yield4.45%
Dividend Yield2.60%
Growth & Risk
EPS 5Y CAGR+3.49%
Revenue 5Y CAGR+8.14%
FCF 5Y CAGR-2.65%
Dividends 5Y CAGR+7.92%
Beta (5Y)0.46
Sharpe Ratio0.84